These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

257 related items for PubMed ID: 29866846

  • 1. Spatially modulated ephrinA1:EphA2 signaling increases local contractility and global focal adhesion dynamics to promote cell motility.
    Chen Z, Oh D, Biswas KH, Yu CH, Zaidel-Bar R, Groves JT.
    Proc Natl Acad Sci U S A; 2018 Jun 19; 115(25):E5696-E5705. PubMed ID: 29866846
    [Abstract] [Full Text] [Related]

  • 2. EphrinA1 activates a Src/focal adhesion kinase-mediated motility response leading to rho-dependent actino/myosin contractility.
    Parri M, Buricchi F, Giannoni E, Grimaldi G, Mello T, Raugei G, Ramponi G, Chiarugi P.
    J Biol Chem; 2007 Jul 06; 282(27):19619-28. PubMed ID: 17449913
    [Abstract] [Full Text] [Related]

  • 3. Upregulation of EphA2 during in vivo and in vitro renal ischemia-reperfusion injury: role of Src kinases.
    Baldwin C, Chen ZW, Bedirian A, Yokota N, Nasr SH, Rabb H, Lemay S.
    Am J Physiol Renal Physiol; 2006 Nov 06; 291(5):F960-71. PubMed ID: 16735461
    [Abstract] [Full Text] [Related]

  • 4. Cell adhesion and EGFR activation regulate EphA2 expression in cancer.
    Larsen AB, Stockhausen MT, Poulsen HS.
    Cell Signal; 2010 Apr 06; 22(4):636-44. PubMed ID: 19948216
    [Abstract] [Full Text] [Related]

  • 5. Bidirectional signalling between EphA2 and ephrinA1 increases tubular cell attachment, laminin secretion and modulates erythropoietin expression after renal hypoxic injury.
    Rodriguez S, Rudloff S, Koenig KF, Karthik S, Hoogewijs D, Huynh-Do U.
    Pflugers Arch; 2016 Aug 06; 468(8):1433-48. PubMed ID: 27228995
    [Abstract] [Full Text] [Related]

  • 6. EphrinA1 repulsive response is regulated by an EphA2 tyrosine phosphatase.
    Parri M, Buricchi F, Taddei ML, Giannoni E, Raugei G, Ramponi G, Chiarugi P.
    J Biol Chem; 2005 Oct 07; 280(40):34008-18. PubMed ID: 16051609
    [Abstract] [Full Text] [Related]

  • 7. EphrinA1-induced cytoskeletal re-organization requires FAK and p130(cas).
    Carter N, Nakamoto T, Hirai H, Hunter T.
    Nat Cell Biol; 2002 Aug 07; 4(8):565-73. PubMed ID: 12134157
    [Abstract] [Full Text] [Related]

  • 8. Redox regulation of ephrin/integrin cross-talk.
    Buricchi F, Giannoni E, Grimaldi G, Parri M, Raugei G, Ramponi G, Chiarugi P.
    Cell Adh Migr; 2007 Aug 07; 1(1):33-42. PubMed ID: 19262085
    [Abstract] [Full Text] [Related]

  • 9. The EphA2 receptor and ephrinA1 ligand in solid tumors: function and therapeutic targeting.
    Wykosky J, Debinski W.
    Mol Cancer Res; 2008 Dec 07; 6(12):1795-806. PubMed ID: 19074825
    [Abstract] [Full Text] [Related]

  • 10. Activation of erythropoietin-producing hepatocellular receptor A2 attenuates cell adhesion of human fallopian tube epithelial cells via focal adhesion kinase dephosphorylation.
    Yang XY, Zhu WJ, Jiang H.
    Mol Cell Biochem; 2012 Feb 07; 361(1-2):259-65. PubMed ID: 22009484
    [Abstract] [Full Text] [Related]

  • 11. EphA2 receptor activation by monomeric Ephrin-A1 on supported membranes.
    Xu Q, Lin WC, Petit RS, Groves JT.
    Biophys J; 2011 Dec 07; 101(11):2731-9. PubMed ID: 22261062
    [Abstract] [Full Text] [Related]

  • 12. Spatial organization of EphA2 at the cell-cell interface modulates trans-endocytosis of ephrinA1.
    Greene AC, Lord SJ, Tian A, Rhodes C, Kai H, Groves JT.
    Biophys J; 2014 May 20; 106(10):2196-205. PubMed ID: 24853748
    [Abstract] [Full Text] [Related]

  • 13. Tobacco smoke induces epithelial barrier dysfunction via receptor EphA2 signaling.
    Nasreen N, Khodayari N, Sriram PS, Patel J, Mohammed KA.
    Am J Physiol Cell Physiol; 2014 Jun 15; 306(12):C1154-66. PubMed ID: 24717580
    [Abstract] [Full Text] [Related]

  • 14. Ligand-independent activation of EphA2 by arachidonic acid induces metastasis-like behaviour in prostate cancer cells.
    Tawadros T, Brown MD, Hart CA, Clarke NW.
    Br J Cancer; 2012 Nov 06; 107(10):1737-44. PubMed ID: 23037715
    [Abstract] [Full Text] [Related]

  • 15. Receptor EphA2 activation with ephrinA1 suppresses growth of malignant mesothelioma (MM).
    Nasreen N, Mohammed KA, Lai Y, Antony VB.
    Cancer Lett; 2007 Dec 18; 258(2):215-22. PubMed ID: 17949899
    [Abstract] [Full Text] [Related]

  • 16. Kinase-dependent and -independent roles of EphA2 in the regulation of prostate cancer invasion and metastasis.
    Taddei ML, Parri M, Angelucci A, Onnis B, Bianchini F, Giannoni E, Raugei G, Calorini L, Rucci N, Teti A, Bologna M, Chiarugi P.
    Am J Pathol; 2009 Apr 18; 174(4):1492-503. PubMed ID: 19264906
    [Abstract] [Full Text] [Related]

  • 17. Soluble monomeric EphrinA1 is released from tumor cells and is a functional ligand for the EphA2 receptor.
    Wykosky J, Palma E, Gibo DM, Ringler S, Turner CP, Debinski W.
    Oncogene; 2008 Dec 11; 27(58):7260-73. PubMed ID: 18794797
    [Abstract] [Full Text] [Related]

  • 18. EphrinA1-EphA2 interaction-mediated apoptosis and FMS-like tyrosine kinase 3 receptor ligand-induced immunotherapy inhibit tumor growth in a breast cancer mouse model.
    Tandon M, Vemula SV, Sharma A, Ahi YS, Mittal S, Bangari DS, Mittal SK.
    J Gene Med; 2012 Feb 11; 14(2):77-89. PubMed ID: 22228563
    [Abstract] [Full Text] [Related]

  • 19. Activation of EphA2 kinase suppresses integrin function and causes focal-adhesion-kinase dephosphorylation.
    Miao H, Burnett E, Kinch M, Simon E, Wang B.
    Nat Cell Biol; 2000 Feb 11; 2(2):62-9. PubMed ID: 10655584
    [Abstract] [Full Text] [Related]

  • 20. EphA2 promotes cell adhesion and spreading of monocyte and monocyte/macrophage cell lines on integrin ligand-coated surfaces.
    Saeki N, Nishino S, Shimizu T, Ogawa K.
    Cell Adh Migr; 2015 Feb 11; 9(6):469-82. PubMed ID: 26565750
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.